As many of you may know, the FDA approved the Gallium 68 PET Scan in December 2020, although it is currently only available in Los Angles, and San Francisco.
We now have a second PSMA PET Scan that has been approved by the FDA. This new PSMA scan, approved on May 27th, 2021, is called PYLARIFY (or PyL). This Scan will be available very quickly in “Mid-Atlantic and southern regions” of the US, but not widely available for a while in other areas of the country, as the company (Progenics/ Lantheus) will need to ramp up their production abilities. We believe that this new PSMA scan will become widely obtainable throughout the US, by the end of 2021.
Watch this blog, or www.lantheus.com for updates.
Both of the approved PSMA PET Scans are approved for two types of prostate cancer patients:
• “…with suspected metastasis who are candidates for initial definitive therapy.”
• “…with suspected recurrence based on elevated serum prostate specific antigen (PSA) level.”
Dr’s Sartor, Morgans, Koo, and Shore explain more in THIS VIDEO.
Don’t forget to Subscribe to Cancer ABCs emails here for more detailed information.
